Histopathological biomarkers for predicting the tumour accumulation of nanomedicines
Jan‐Niklas May(RWTH Aachen University), Twan Lammers(Integrated Oncology (United States))
Cited by 43
Related Papers
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k
Tumour-targeted nanomedicines: principles and practice
|British Journal of Cancer|2008|535